港交所(0388.HK)漲超2% 創歷史新高
格隆匯2月17日丨港交所(0388.HK)午後持續上行,現漲2.55%,報562港元,盤中高見563港元,創歷史新高,成交額近14億港元,最新總市值7125億港元。港交所昨日舉行牛年新春開市儀式,主席史美倫稱,2020年是港交所豐收一年,在市場推出多項新產品,港股新股集資創近10年新高,隨疫苗推出為經濟帶來新機遇,而全球對可持續發展日感重要,港交所會推動和參與可持續發展。港交所代理行政總裁戴志堅稱,港交所1月日均成交額達2400億港元,為歷年新高,新經濟、生物科技新股持續火熱,會致力以主要上市、二次上市方式,為市場增加投資機會。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.